Okay, let's tackle this question about Guillain-Barré Syndrome (GBS). The user wants the correct answer to be identified, specifically which treatment option is not useful. First, I need to recall the standard treatments for GBS.

Core Concept: GBS is an autoimmune disorder where the immune system attacks the peripheral nerves, leading to muscle weakness and sometimes paralysis. The main treatments are intravenous immunoglobulin (IVIG) and plasma exchange (PEX), which help modulate the immune response.

Now, the correct answer is the one that's not a standard treatment. Let's say the options are A. IVIG, B. PEX, C. Corticosteroids, D. Supportive care. The correct answer would be C because corticosteroids aren't recommended for GBS. Studies have shown that corticosteroids don't improve outcomes and might even worsen them by increasing complications like infections.

Why is IVIG correct? It works by neutralizing pathogenic antibodies and modulating immune activity. Plasma exchange removes harmful antibodies from the blood. Supportive care, like respiratory support and physical therapy, is crucial in managing symptoms and preventing complications.

For the incorrect options: Option A (IVIG) is a standard treatment. Option B (PEX) is also standard. Option D (supportive care) is essential. So, the exception is corticosteroids. The clinical pearl here is that corticosteroids are contraindicated in GBS, which is a common exam point. Students might confuse this with other autoimmune diseases where steroids are used, but for GBS, it's a red flag.

**Core Concept**
Guillain-Barré Syndrome (GBS) is an autoimmune-mediated inflammatory demyelinating polyneuropathy. The primary therapeutic goals are immune modulation and supportive care. Evidence-based treatments include intravenous immunoglobulin (IVIG) and plasma exchange (PEX).

**Why the Correct Answer is Right**
Corticosteroids (e.g., prednisolone) are **not recommended** for GBS due to lack of efficacy and potential harm. Randomized controlled trials (e.g., Cochrane reviews) show no clinical benefit and increased risks of complications like infections and hyperglycemia. GBS pathogenesis involves autoantibodies and complement-mediated nerve injury, which are not effectively targeted by corticosteroids.

**Why Each Wrong Option is Incorrect**
**Option A:** IVIG is a first-line therapy. It modulates immune activity via Fc receptor blockade and anti-inflammatory cytokine effects.
**Option B:** Plasma exchange removes pathogenic antibodies and immune complexes, improving outcomes.
**Option D:** Supportive care (e.g., respiratory support, physiotherapy) is critical to manage complications like respiratory failure and DVT.

**Clinical Pearl / High-Yield Fact**
**Steroids are contraindicated in GBS**—this is a high-yield exam point. Remember: *“GBS and steroids don’t mix; IVIG and PEX are the tricks.”* Confusion with other autoimmune disorders (e.g., MS) where steroids are used is common but incorrect here.

**Correct Answer: C. Corticosteroids**

✓ Correct Answer: B. Intra-venous methotrexate